Prognostic and Predictive Biomarkers

While prognostic biomarkers hint at the likely outcome of a patient with a particular disease regardless of their treatment, predictive biomarkers provide information on whether that patient will respond to a certain agent. Some markers provide both of these functions. For instance, estrogen receptor positivity in breast cancer patients indicates a favorable prognosis (providing prognostic information); at the same time, it means that the patient will probably respond to endocrine therapy.

 

  • Prognostic Biomarkers: Analysis of Mutations and Polymorphisms
  • Prognostic Biomarkers: Analysis of Gene and MicroRNA
  • Predictive Biomarkers: Analysis of Mutations and Polymorphisms
  • Predictive Biomarkers: Analysis of Gene and MicroRNA

Related Conference of Prognostic and Predictive Biomarkers

July 28-29, 2025

45th Euro Congress on Cancer Science & Therapy

Paris, France
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain
October 22-23, 2025

35th Experts Meet On Cancer Research & Therapy

Paris, France
October 24-25, 2025

25th World Congress on Cancer and Diagnostics

Zurich, Switzerland
November 20-21, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
November 24-25, 2025

43rd World Cancer Conference

Barcelona, Spain
December 08-09, 2025

13th Euro Breast Cancer and Therapeutics

Aix-en-Provence, France
February 19-20, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA
February 19-20, 2026

8th International Conference on Women Oncology

Miami, USA
March 23-24, 2026

16th World Congress on Breast Cancer Research & Therapies

Aix-en-Provence, France

Prognostic and Predictive Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in